MNMDMind Medicine (MindMed) Inc.

Nasdaq mindmed.co


$ 9.14 $ -0.49 (-5.1 %)    

Thursday, 09-May-2024 15:59:51 EDT
QQQ $ 441.33 $ 0.96 (0.22 %)
DIA $ 394.43 $ 3.52 (0.9 %)
SPY $ 520.56 $ 2.98 (0.58 %)
TLT $ 90.69 $ 0.44 (0.49 %)
GLD $ 216.93 $ 3.37 (1.58 %)
$ 9.12
$ 9.01
$ 0.00 x 0
$ 0.00 x 0
$ 7.97 - $ 9.16
$ 2.41 - $ 12.22
2,839,564
na
436.49M
$ 7.36
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 03-09-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-16-2022 03-31-2022 10-Q
10 03-28-2022 12-31-2021 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 mind-medicine-presents-new-studies-at-ispor-2024-showing-growing-burden-and-impact-of-generalized-anxiety-disorder-in-the-us

-GAD Diagnosis Increases Healthcare Costs and Decreases Work Productivity and Health-Related Quality of Life--People with Undia...

 mind-medicine-q1-2024-gaap-eps-114-misses-053-estimate

Mind Medicine (NASDAQ:MNMD) reported quarterly losses of $(1.14) per share which missed the analyst consensus estimate of $(0.5...

Core News & Articles

https://www.marijuanamoment.net/fda-expert-committee-will-review-mdma-assisted-therapy-for-ptsd-next-month/The Food and Drug Ad...

 reported-saturday-mindmed-unveils-phase-2b-data-of-mm120-for-generalized-anxiety-disorder-at-american-psychiatric-association-annual-meeting

-A single oral administration of MM120 100 µg met its primary and key secondary endpoints and maintained clinically and stati...

 leerink-partners-initiates-coverage-on-mind-medicine-with-outperform-rating-announces-price-target-of-20

Leerink Partners analyst Rudy Li initiates coverage on Mind Medicine (NASDAQ:MNMD) with a Outperform rating and announces Pr...

 roblox-tal-education-and-other-big-stocks-moving-higher-on-wednesday

U.S. stocks were lower, with the Dow Jones index falling over 300 points on Wednesday.

 simulations-plus-posts-upbeat-joins-levi-strauss-blackberry-and-other-big-stocks-moving-higher-in-thursdays-pre-market-session

U.S. stock futures were higher this morning, with the Dow futures gaining by around 90 points on Thursday.

Core News & Articles

https://www.marijuanamoment.net/indiana-lawmakers-send-psilocybin-research-funding-bill-to-governor/   The Indiana legislatur...

 why-robinhood-shares-are-trading-higher-by-around-12-here-are-20-stocks-moving-premarket

Shares of Robinhood Markets, Inc. (NASDAQ: HOOD) rose sharply in today’s pre-market trading after the company reported Februar...

 hc-wainwright--co-reiterates-buy-on-mind-medicine-maintains-75-price-target

HC Wainwright & Co. analyst Patrick Trucchio reiterates Mind Medicine (NASDAQ:MNMD) with a Buy and maintains $75 price t...

 why-clover-health-investments-shares-are-trading-higher-by-11-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported b...

 rbc-capital-maintains-outperform-on-mind-medicine-raises-price-target-to-22

RBC Capital analyst Brian Abrahams maintains Mind Medicine (NASDAQ:MNMD) with a Outperform and raises the price target from ...

 sp-500-gains-1-kroger-earnings-top-views

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining over 250 points on Thursday. The Dow tr...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION